Navigation Links
PharmAthene Secures $7.5 Million Credit Facility From GE Capital, Healthcare Financial Services
Date:4/3/2012

ANNAPOLIS, Md., April 3, 2012 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP) today announced that it has secured $7.5 million in senior secured credit facilities from GE Capital, Healthcare Financial Services consisting of a $2.5 million term loan and a revolving line of credit of up to $5 million.

Linda L. Chang, Senior Vice President and Chief Financial Officer, commented, "We are very pleased to partner with GE Capital – a recognized leader in healthcare financing.  This financing further strengthens our balance sheet and provides us with increased flexibility to manage our working capital requirements."

"Our expected 2012 monthly cash burn is less than $500,000 per month based on currently projected activities on our contracts," Ms. Chang continued. "Given that PharmAthene had $19.2 million in cash and cash equivalents, short term investments, and net receivables as of December 31, 2011, this financing provides an additional liquidity cushion until the time in 2013 when we anticipate receiving final resolution of the litigation with SIGA Technologies."

For a summary of the terms of the credit facility, see the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on the date hereof.

About PharmAthene, Inc.

PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons.  PharmAthene's lead product development programs include:

  • SparVax™ a second generation recombinant protective antigen (rPA) anthrax vaccine
  • Valortim® a fully human monoclonal antibody for the prevention and treatment of anthrax infection
  • Recombinant BChE a novel bioscavenger for
    '/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. PharmAthene to Present at the 24th Annual ROTH Conference on Monday, March 12, 2012
2. PharmAthene to Present at the Noble Financial Eighth Annual Equity Conference on Tuesday, January 17, 2012
3. PharmAthene Reports Third Quarter 2011 Financial and Operating Results
4. PharmAthene Progresses Second Generation rPA Anthrax Vaccine
5. PharmAthene Appoints Brian A. Markison to the Companys Board of Directors
6. PharmAthene Achieves Significant Progress in SparVax™ Anthrax Vaccine Program
7. Department of Defense Awards $5.7 Million Contract to PharmAthene for Nerve Agent Medical Countermeasure Program
8. PharmAthene Selected for Inclusion in the Russell Global Index and Russell 3000 Index
9. PharmAthene Achieves Anthrax Vaccine Program Milestone and Successfully Completes Technology Transfer
10. PharmAthene Completes $6.5 Million Registered Direct Offering
11. PharmAthene Reports First Quarter 2011 Financial and Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Sept. 3, 2015  StemProtein LLC, a leading ... spinout of Stemedica Cell Technologies Inc., announced today ... as CEO of StemProtein. Silberg will help advance ... preserving Stem Cell Factors (SCFs), a significant consumer ... the pharmaceutical and biopharmaceutical industries with substantial executive ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... non-invasive hydration monitoring wearable early 2016. , The device, called the Halo ... proprietary optical and electrical sensing technology. These sensors track trending interstitial fluid levels ...
(Date:9/2/2015)... 2, 2015 Research and Markets ... of Jain PharmaBiotech,s new report "Nanobiotechnology ... offering. An increasing use ... industries is anticipated. Nanotechnology will be applied ... from formulations for optimal delivery to diagnostic ...
(Date:9/2/2015)... , Sep. 02, 2015 ... has announced the addition of Jain PharmaBiotech,s new ... and Companies" to their offering. ... based on technologies and applications. The report starts ... for estimation of markets. Technologies include array comparative ...
Breaking Biology Technology:StemProtein Names Thomas H. Silberg As CEO, To Focus On Stem Cell Secreted Proteins Addresing A Variety Of Health And Beauty Related Needs 2StemProtein Names Thomas H. Silberg As CEO, To Focus On Stem Cell Secreted Proteins Addresing A Variety Of Health And Beauty Related Needs 3Technology Startup Halo Wearables to Unveil Non-Invasive Hydration Monitoring Device Early 2016 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 3Global Biochips and Microarrays Technologies, Markets and Companies Report 2015 with Market Size in 2014 and Projected Value for the Years 2019 and 2024 2
... Investigating programmed cell death , Wei-ping Yang ... ,Stratagene , The apoptotic response is a complex ... of genes that interact with and respond to ... ,sets that are specific for genes ...
... pathway activation , Li Xu Tim Sanchez ... Stratagenes PathDetect in vivo signal transduction pathway,reporting systems ... activation of signal,transduction pathways. To expand the utility ... and pFA-Elk1 plasmids with new, improved fusion,trans-activator plasmids. ...
... with TKB1 competent cells , David ... for Molecular Biology and Biotechnology, McMaster University,Ontario, ... bacteria are used to affinity purify,cellular proteins, ... on,the ErbB2/Neu receptor tyrosine kinase (RTK). This ...
Cached Biology Technology:RT-PCR Primers for the Study of Apoptosis 2RT-PCR Primers for the Study of Apoptosis 3RT-PCR Primers for the Study of Apoptosis 4RT-PCR Primers for the Study of Apoptosis 5RT-PCR Primers for the Study of Apoptosis 6RT-PCR Primers for the Study of Apoptosis 7Improved Vectors for PathDetect Trans-Reporting Systems 2Improved Vectors for PathDetect Trans-Reporting Systems 3Improved Vectors for PathDetect Trans-Reporting Systems 4Improved Vectors for PathDetect Trans-Reporting Systems 5TKB1 Cells Identify Receptor Tyrosine Kinase Interacting Proteins 2TKB1 Cells Identify Receptor Tyrosine Kinase Interacting Proteins 3TKB1 Cells Identify Receptor Tyrosine Kinase Interacting Proteins 4TKB1 Cells Identify Receptor Tyrosine Kinase Interacting Proteins 5
(Date:8/6/2015)... Aug. 6, 2015  Today, U.S. Congressman ... Crossmatch ™ to learn firsthand how Silicon Valley ... Crossmatch is a world leader in multi-factor identity ... are helping federal agencies and commercial organizations achieve ... "The vast majority of network breaches ...
(Date:8/5/2015)... CHICAGO , August 5, 2015 ... Identity & Access Management Market by Software, Services, Vertical (BFSI, ... Chemical/Pharma), & Geography - Global Forecast to 2020", published ... Access Management Market globally into various segments. The global ... in 2014 to $546.2 Million by 2019, at a ...
(Date:8/4/2015)... DUBLIN , Aug. 04, 2015 /PRNewswire/ ... ( http://www.researchandmarkets.com/research/nvh7k2/digital_forensics ) has announced the addition ... Component (Hardware, Software, and Service), Sub-Segment (Computer ... Cloud Forensics), Tool Types, Service, Vertical and ... report to their offering. By ...
Breaking Biology News(10 mins):Rep. Honda to Visit Crossmatch in Redwood City 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2
... ITHACA, N.Y. - A new study of maize has ... the genome. New techniques may allow breeders and researchers to ... new varieties that were not easily possible before. Publishing ... researchers, whose senior and first author are at Cornell, have ...
... COLLEGE PARK, Md.-John Fisher, associate professor in the Fischell ... the 2009 Bioscience Research and Technology Review Day with ... other types of tissue for implantation. Fisher,s technology ... minute pitch by faculty members and graduate students at ...
... the first time, scientists have successfully used a method called ... for a mendelian disorder. Mendelian disorders, such as ... one or more mutations in a single gene, typically a ... code for proteins taken together are called the exome. The ...
Cached Biology News:New map of variation in maize genetics holds promise for developing new varieties 2Bioreactor for bone tissue engineering wins professor venture fair 2Bioreactor for bone tissue engineering wins professor venture fair 3Causative gene of a rare disorder discovered by sequencing only protein-coding regions of genome 2Causative gene of a rare disorder discovered by sequencing only protein-coding regions of genome 3
BKBeta2 potassium channel Antigen: Fusion protein amino acids 1-41 (N-terminus) and 218-235 (C-terminus) of mouse BKBeta2 Accession Number: Q9CZM9...
Gap junction protein, beta 2, 26kDa (connexin 26) Antigen: Peptide...
HSPBP1 Antibody...
... advanced RACE (rapid amplification of cDNA ends) ... full-length 5' and 3' cDNA ends. The ... Reverse Transcriptase (RT) for improved amplification of ... complex mRNA. The RNase H portion of ...
Biology Products: